Moore MA - Search Results

1

Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival.

Wu KD, Orme LM, Shaughnessy J Jr, Jacobson J, Barlogie B, Moore MA. Wu KD, et al. Among authors: moore ma. Blood. 2003 Jun 15;101(12):4982-9. doi: 10.1182/blood-2002-11-3451. Epub 2003 Feb 27. Blood. 2003. PMID: 12609839 Free article.

2

Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma.

Wang ES, Wu K, Chin AC, Chen-Kiang S, Pongracz K, Gryaznov S, Moore MA. Wang ES, et al. Among authors: moore ma. Blood. 2004 Jan 1;103(1):258-66. doi: 10.1182/blood-2003-02-0546. Epub 2003 Sep 11. Blood. 2004. PMID: 12969977 Free article.

3

Determination of telomerase activity and telomere length.

Wu KD, Moore MA. Wu KD, et al. Among authors: moore ma. Methods Mol Med. 2005;113:207-23. doi: 10.1385/1-59259-916-8:207. Methods Mol Med. 2005. PMID: 15968105

4

Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication.

Gammaitoni L, Weisel KC, Gunetti M, Wu KD, Bruno S, Pinelli S, Bonati A, Aglietta M, Moore MA, Piacibello W. Gammaitoni L, et al. Among authors: moore ma. Blood. 2004 Jun 15;103(12):4440-8. doi: 10.1182/blood-2003-09-3079. Epub 2004 Jan 15. Blood. 2004. PMID: 14726371 Free article.

5

Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis.

Wu KD, Zhou L, Burtrum D, Ludwig DL, Moore MA. Wu KD, et al. Among authors: moore ma. Cancer Immunol Immunother. 2007 Mar;56(3):343-57. doi: 10.1007/s00262-006-0196-9. Epub 2006 Jul 11. Cancer Immunol Immunother. 2007. PMID: 16832681 Free PMC article.

6

Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo.

Wu KD, Cho YS, Katz J, Ponomarev V, Chen-Kiang S, Danishefsky SJ, Moore MA. Wu KD, et al. Among authors: moore ma. Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10640-5. doi: 10.1073/pnas.0504512102. Epub 2005 Jul 19. Proc Natl Acad Sci U S A. 2005. PMID: 16030145 Free PMC article.

7

Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells.

Wen VW, Wu K, Baksh S, Hinshelwood RA, Lock RB, Clark SJ, Moore MA, Mackenzie KL. Wen VW, et al. Among authors: moore ma. Cancer Res. 2006 Nov 15;66(22):10691-700. doi: 10.1158/0008-5472.CAN-06-0979. Cancer Res. 2006. PMID: 17108106

8

Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells.

Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MA. Engelhardt M, et al. Among authors: moore ma. Blood. 1997 Jul 1;90(1):182-93. Blood. 1997. PMID: 9207452 Free article.

9

Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.

Schuringa JJ, Wu K, Morrone G, Moore MA. Schuringa JJ, et al. Among authors: moore ma. Stem Cells. 2004;22(7):1191-204. doi: 10.1634/stemcells.2004-0033. Stem Cells. 2004. PMID: 15579639

10

Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element.

Mulloy JC, Cammenga J, Berguido FJ, Wu K, Zhou P, Comenzo RL, Jhanwar S, Moore MA, Nimer SD. Mulloy JC, et al. Among authors: moore ma. Blood. 2003 Dec 15;102(13):4369-76. doi: 10.1182/blood-2003-05-1762. Epub 2003 Aug 28. Blood. 2003. PMID: 12946995 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

958 results

Search Page

Filters